Search

Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) antigen (propiolactone inactivated)

Inactivated viruses cannot replicate and thus cannot cause disease from infection, even in immunocompromised individuals. … These vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which results in an immunological defense against future exposure to the virus, or "antigen

Recombinant alpha 1-antitrypsin

The proteinase/antiproteinase balance is believed to be important for maintaining healthy skin. The rAAT topical gel (Dermolastin™) is indicated for patients with atopic dermatitis and psoriasis. … Alpha 1-antitrypsin is a glycoprotein primarily produced by hepatocytes, and to a lesser extent, immune system cells.

Sitimagene ceradenovec

Sitimagene ceradenovec is a novel gene-based product for the treatment of patients with operable high grade glioma, a type of malignant brain tumour, given in addition to standard surgery and radiotherapy … It is being developed by Ark Therapeutics.

Tangerine peel

Tangerine peel is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Coconut oil

Coconut oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Sunflower oil

Sunflower oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Chondrus crispus

Chondrus crispus is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen

grown in another culture. … Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by *Neisseria

NasoVAX

As of June 2020, NasoVAX is being evaluated in a Phase 2 clinical trial for safety and effectivness in preventing worsening symptoms in hospitalized COVID-19 patients (NCT04442230). … NasoVAX contains replication-deficient adenovirus vectors in suspension. It is a vaccine administered through a nasal spray that expresses influenza hemagglutinin in nasal epithelial cells[L16313].

Oxolinic acid